The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) will release fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, followed by a conference call the same day at 5:00 p.m. ET. Investors can join via phone or webcast.
A replay will be available two hours after the call through Thursday, March 19, 2026 using the provided passcode; international dial-in and webcast details are available on the investor relations site.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Momentum scanner shows only one peer in motion (AGL down 5.18%), while other close peers like JYNT, BTMD, CCRN, and CYH show mixed, modest gains or losses. This points to stock-specific dynamics rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 25 | Investor conferences | Positive | +10.8% | Announced executive participation in three March 2026 investor conferences. |
| Feb 23 | Board appointment | Positive | -0.4% | Added experienced healthcare executive Kim Tzoumakas to the board. |
| Jan 12 | Guidance reaffirmed | Positive | -7.9% | Reaffirmed 2025 guidance and gave 2026 revenue and EBITDA outlook. |
| Jan 09 | Leadership promotions | Positive | -3.0% | Promoted new CIO and CPO to support technology and people strategy. |
| Jan 05 | Board appointment | Positive | +6.8% | Added Mark Stolper, a seasoned CFO, to the board for growth support. |
Recent news has mostly been positive or strategic, yet price reactions show more divergences than alignments, indicating that good news has not consistently translated into gains.
Over the last few months, TOI issued several strategic and operational updates. On Jan 5, 2026 and Feb 23, 2026, new board members were added, and on Jan 9, 2026 leadership promotions were announced. On Jan 12, 2026, TOI reaffirmed 2025 guidance and outlined a preliminary 2026 outlook. On Feb 25, 2026, it disclosed participation in multiple March investor conferences. Today’s earnings release date and call fit into this pattern of active investor communication and governance updates.
Market Pulse Summary
This announcement sets the timetable for TOI’s fourth quarter and full year 2025 earnings, with results and a conference call on March 12, 2026 at 5:00 p.m. ET. It follows recent updates on guidance, leadership promotions, and new board members earlier in 2026. With shares trading below the 200-day MA of $3.33, investors may focus on how upcoming results relate to prior outlook commentary and recent strategic changes when assessing the company’s trajectory.
AI-generated analysis. Not financial advice.
CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13758646. The replay will be available until Thursday March 19, 2026.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
When will TOI (NASDAQ: TOI) release Q4 and full-year 2025 results?
How can investors join The Oncology Institute (TOI) conference call on March 12, 2026?
What are the dial-in numbers and passcode for the TOI (NASDAQ: TOI) earnings call?
When and how can I access the replay of The Oncology Institute (TOI) March 12, 2026 call?
Where is The Oncology Institute (TOI) hosting the webcast for the March 12, 2026 earnings call?
